|
AGK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.35870220524725E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.33020000254214E-09 |
| Normal-vs-Stage2 |
3.835900E-02 |
| Normal-vs-Stage3 |
1.996780E-01 |
| Normal-vs-Stage4 |
6.058600E-01 |
| Stage1-vs-Stage2 |
8.733600E-01 |
| Stage1-vs-Stage3 |
1.217620E-02 |
| Stage1-vs-Stage4 |
1.261790E-01 |
| Stage2-vs-Stage3 |
1.952630E-01 |
| Stage2-vs-Stage4 |
2.558400E-01 |
| Stage3-vs-Stage4 |
7.952400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02240005350751E-09 |
| Normal-vs-AfricanAmerican |
3.190500E-04 |
| Normal-vs-Asian |
2.195000E-01 |
| Caucasian-vs-AfricanAmerican |
9.282600E-01 |
| Caucasian-vs-Asian |
8.646800E-01 |
| AfricanAmerican-vs-Asian |
8.603600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.73421343530845E-12 |
| Normal-vs-Female |
2.340300E-03 |
| Male-vs-Female |
5.631700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.844100E-02 |
| Normal-vs-Extreme_Weight |
1.50499999995723E-06 |
| Normal-vs-Obese |
3.191100E-04 |
| Normal-vs-Extreme_Obese |
1.053830E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.743600E-01 |
| Normal_Weight-vs-Obese |
6.367200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.720000E-01 |
| Extreme_Weight-vs-Obese |
4.667600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.416200E-01 |
| Obese-vs-Extreme_Obese |
5.676400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.655700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.00960004193007E-09 |
| Normal-vs-Age(61-80Yrs) |
1.92129999998514E-06 |
| Normal-vs-Age(81-100Yrs) |
2.214400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.450200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.593000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.290200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.965830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.535000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.522200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6242562850266E-12 |
| Normal-VS-Type2 PRCC |
6.500400E-01 |
| Normal-VS-KIRP CIMP |
5.297400E-01 |
| Normal-VS-Unclassified PRCC |
2.624000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.91559990092571E-10 |
| Type1 PRCC-VS-KIRP CIMP |
1.381320E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.497500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.163000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.045600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.405610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.888490E-02 |
| Normal-vs-N1 |
1.442790E-01 |
| Normal-vs-N2 |
1.242150E-01 |
| N0-vs-N1 |
3.504800E-01 |
| N0-vs-N2 |
1.860240E-01 |
| N1-vs-N2 |
1.134980E-01 |
|
|
